Form4.ai tracks every SEC insider trade in real time. See every MDGL insider filing with a free account — no card.

See every MDGL insider filing

Free account

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Insider Trading

MADRIGAL PHARMACEUTICALS, INC. (MDGL) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $6.6M. Most recent filing: Sept. 11, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $6.6M (100%)
  • Sold $6.6M · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 2 (67%) Grants, exercises & other: 1 (33%)
  • Sales 2 · 67%
  • Grants, exercises & other 1 · 33%

At a glance

Insiders trading
3
Largest buy
—
Most recent filing
Sep 11, 2026

Latest MDGL Form 4 filings

Date Insider Trade Value Price since buy
Sep 11, 2026 SEC filing Sibold William John President and CEO Sold $6,239,198 —
Aug 20, 2026 SEC filing Kelley Shannon T General Counsel Sold $341,940 —
Aug 18, 2026 SEC filing REED JOHN C Director Grant / award — —

See every MDGL insider trade

Create a free account to see all 3 MDGL filings from the last 90 days. No card needed.

Create free account

Want MDGL insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.